Summary
Datamonitor's Watson Pharmaceuticals, Inc. Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Watson Pharmaceuticals (Watson) specializes in the development of branded and non patented pharmaceutical products. The company markets a broad range of generic products for the nephrology, urology, pain management, and therapeutic dermatology markets. Watson operates manufacturing, distribution, research and development, and administrative facilities primarily in the US. It is headquartered in Corona, California and employs about 5,800 people. The company recorded revenues of $1,979.2 million during the fiscal year ended December 2006, an increase of 20.2% over 2005. The operating loss of the company was $422.1 million during fiscal year 2006, against an operating profit of $218.5 million in 2005. The net loss was $445 million in fiscal year 2006, against a net profit of $138.5 million in 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
|
